Regulations.gov document
Determining Whether To Submit an Abbreviated New Drug Application or a 505(b)(2)…
Notice · FDA-2017-D-5974 · posted May 10, 2019
Key facts
| Document ID | FDA-2017-D-5974-0010 |
|---|---|
| Title | Determining Whether To Submit an Abbreviated New Drug Application or a 505(b)(2) Application; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-5974 |
| Posted | May 10, 2019 |
| Federal Register citation | 84 FR 20637 |
| FR document number | 2019-09662 |
| Comment period opens | May 10, 2019 |
| Effective date | May 10, 2019 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: